Our Science & Research

We believe that every medicine, product and brand that we develop must launch from a foundation that is backed by precise research and meticulous development programs. We are currently running various initiatives with our trusted partners to develop therapies and medicines that will alleviate suffering, improve consumers’ overall well-being through nutraceuticals, functional foods, topicals and cosmetics.

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects

of Psilocybe Natalensis Magic Mushroom

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin‐1‐induced hypertrophy and cell injury in cardiomyocytes

Squared2 Up: Newsletter of the Faculty of Natural and Agricultural Sciences

Our Psilocybin & CBD Products

  • Medicines & Indications
  • Nutraceuticals & Functional Foods
  • Cosmetics

Our Research Applications

At the core of our business we are focusing on the science and research behind medicinal cannabis and medicinal mushrooms.

  • Psilocybin research for medical conditions such as alcohol addiction and related mental health diseases & cardiovascular conditions.
    – Earned: 2 Year psilocybin clinical trial for alcoholism and other indications.
    – Concluded: In vivo and in vitro phase successfully.
    – Extraction: Study of psilocybin from four species of mushrooms.
    – Planning: Phase I clinical human trial 2021.

  • Cannabinoid & Mushroom Study, African Research Council, South Africa –White Paper: Four medicinal mushrooms in functional beverages.
    Next Steps: Research and development of undiscovered properties of cannabinoids for the treatment of inflamatory and chronic diseases.

  • Cannabis Manufacturing, MediGrow Africa – Tsime Pharmaceuticals
    Acquisition to cultivate, extract and process cannabis in Lesotho – licensed for 10 years.

Schedule I Drugs (Psychedelics) Psilocybin.
Developing indications for new therapies that
help patients who suffer from mental disorders,
addiction, Alzheimer’s and Parkinson’s

M2Bio_Banner_Images

NEXT STEPS

Research and development of undiscovered properties of cannabinoids for the treatment of inflammatory and chronic diseases.

Our Trusted Partners

We have standing relationships and agreements with the best universities, research institutions and various stakeholders around the world. Together with our valued partners we are developing medicines and consumables for a world that needs new and inspiring solutions.

“It is time we get back to our roots. Research has proven the benefits of Mother Nature’s plant-based medicines, mushrooms and cannabis, their active ingredients –
Psilocybin and Cannabinoids.”

DR. ANNA MORERA LERALTA, Doctor In Medicine And Surgery, Vall D’hebron Hospital, University Of Barcelona